245 related articles for article (PubMed ID: 31206403)
1. The relationship between protein convertase subtilisin kexin type-9 levels and extent of coronary artery disease in patients with non-ST-elevation myocardial infarction.
Dalgic Y; Abaci O; Kocas C; Cetinkal G; Dalgic SN; Buyuk A; Ser OS; Batit S; Arat A; Gurmen AT
Coron Artery Dis; 2020 Jan; 31(1):81-86. PubMed ID: 31206403
[TBL] [Abstract][Full Text] [Related]
2. Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction.
Gao J; Yang YN; Cui Z; Feng SY; Ma J; Li CP; Liu Y
Lipids Health Dis; 2021 May; 20(1):56. PubMed ID: 34044829
[TBL] [Abstract][Full Text] [Related]
3. Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort Study.
Li JJ; Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q
Medicine (Baltimore); 2015 Dec; 94(52):e2426. PubMed ID: 26717403
[TBL] [Abstract][Full Text] [Related]
4. PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography.
Panahi Y; Ghahrodi MS; Jamshir M; Safarpour MA; Bianconi V; Pirro M; Farahani MM; Sahebkar A
Clin Biochem; 2019 Dec; 74():12-18. PubMed ID: 31493378
[TBL] [Abstract][Full Text] [Related]
5. Circulating PCSK9 levels in acute coronary syndrome: Results from the PC-SCA-9 prospective study.
Cariou B; Guérin P; Le May C; Letocart V; Arnaud L; Guyomarch B; Pichelin M; Probst V
Diabetes Metab; 2017 Dec; 43(6):529-535. PubMed ID: 28865748
[TBL] [Abstract][Full Text] [Related]
6. Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease.
Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Liu G; Dong Q; Li JJ
Ann Med; 2015; 47(5):386-93. PubMed ID: 26153823
[TBL] [Abstract][Full Text] [Related]
7. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
[TBL] [Abstract][Full Text] [Related]
8. Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention.
Zhu YM; Anderson TJ; Sikdar K; Fung M; McQueen MJ; Lonn EM; Verma S
Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2254-9. PubMed ID: 26293463
[TBL] [Abstract][Full Text] [Related]
9. Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Choi IJ; Lim S; Lee D; Lee WJ; Lee KY; Kim MJ; Jeon DS
Am J Cardiol; 2020 Oct; 133():54-60. PubMed ID: 32798044
[TBL] [Abstract][Full Text] [Related]
10. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
[TBL] [Abstract][Full Text] [Related]
11. Comparison of coronary atherosclerotic disease burden between ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: Non-culprit Gensini score and non-culprit SYNTAX score.
Tanaka T; Miki K; Akahori H; Imanaka T; Yoshihara N; Kimura T; Yanaka K; Asakura M; Ishihara M
Clin Cardiol; 2021 Feb; 44(2):238-243. PubMed ID: 33368316
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of PCSK9 levels in patients with non-ST elevation myocardial infarction undergoing percutaneous coronary intervention (PCI).
Wang J; Han P; Gao M; Xiao J; Li X; Zhang N; Ma J; Cui Z; Yao T; Chen Y; Gao J; Liu Y
Hellenic J Cardiol; 2022; 63():22-31. PubMed ID: 34058371
[TBL] [Abstract][Full Text] [Related]
13. Correlation of serum PCSK9 in CHD patients with the severity of coronary arterial lesions.
Wang S; Cheng ZY; Zhao ZN; Quan XQ; Wei Y; Xia DS; Li JQ; Hu JL
Eur Rev Med Pharmacol Sci; 2016; 20(6):1135-9. PubMed ID: 27049268
[TBL] [Abstract][Full Text] [Related]
14. Association between circulating proprotein convertase subtilisin/kexin type 9 levels and prognosis in patients with severe chronic kidney disease.
Rasmussen LD; Bøttcher M; Ivarsen P; Jørgensen HS; Nyegaard M; Buttenschøn H; Gustafsen C; Glerup S; Bøtker HE; Svensson M; Winther S
Nephrol Dial Transplant; 2020 Apr; 35(4):632-639. PubMed ID: 30137516
[TBL] [Abstract][Full Text] [Related]
15. Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study.
Gao J; Wang HB; Xiao JY; Ren M; Reilly KH; Li YM; Liu Y
BMJ Open; 2018 Jul; 8(7):e021951. PubMed ID: 29991632
[TBL] [Abstract][Full Text] [Related]
16. The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.
Cao YX; Liu HH; Sun D; Jin JL; Xu RX; Guo YL; Wu NQ; Zhu CG; Li S; Zhang Y; Sun J; Li JJ
Atherosclerosis; 2018 Oct; 277():7-14. PubMed ID: 30170223
[TBL] [Abstract][Full Text] [Related]
17. Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment.
Werner C; Hoffmann MM; Winkler K; Böhm M; Laufs U
Vascul Pharmacol; 2014 Aug; 62(2):94-102. PubMed ID: 24685817
[TBL] [Abstract][Full Text] [Related]
18. Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
Hu D; Yang Y; Peng DQ
Int J Cardiol; 2017 Jan; 227():61-65. PubMed ID: 27846466
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease.
Krychtiuk KA; Lenz M; Hohensinner P; Distelmaier K; Schrutka L; Kastl SP; Huber K; Dostal E; Oravec S; Hengstenberg C; Wojta J; Speidl WS
J Clin Lipidol; 2021; 15(3):512-521. PubMed ID: 33789832
[TBL] [Abstract][Full Text] [Related]
20. Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status.
Li S; Xu RX; Zhang Y; Guo YL; Zhu CG; Liu G; Dong Q; Li JJ
J Endocrinol Invest; 2015 Dec; 38(12):1291-9. PubMed ID: 26003826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
